CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration-Reference-Cited by-同舟云学术

CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration

Published:2018-06-21 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Fox James M.^ORCID,Kausar Fahima,Day Amy,Osborne Michael,Hussain Khansa,Mueller Anja,Lin Jessica,Tsuchiya Tomoko^ORCID,Kanegasaki Shiro,Pease James E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-27710-9.pdf

Reference48 articles.

1. Bachelerie, F. et al. International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors. Pharmacol. Rev. 66, 1–79 (2013).

2. Zlotnik, A. & Yoshie, O. The chemokine superfamily revisited. Immun. 36, 705–716 (2012).

3. Weber, C., Zernecke, A. & Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8, 802–815 (2008).

4. Boring, L., Gosling, J., Cleary, M. & Charo, I. F. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nat. 394, 894–897 (1998).

5. Combadière, C. et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Cir. 107, 1009–1016 (2003).

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer;Cell Reports Medicine;2024-08

2. Proteomics data in vitiligo: a scoping review;Frontiers in Immunology;2024-04-23

3. Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis;Cancer Letters;2024-04

4. Proteomics data in vitiligo: a scoping review;2024-02-27

5. Macrophage modulation in activation process induced immune thrombocytopenia;UNIVERSA MED;2024